アプタマー市場 - 世界の産業規模、シェア、動向、機会、予測：タイプ別、技術別、用途別、エンドユーザー別、地域別、競合別、2020～2030年

世界のアプタマーの市場規模は2024年に20億5,000万米ドルで、予測期間中のCAGRは7.11%で2030年には30億7,000万米ドルに達すると予測されています。

世界のアプタマー市場は、バイオテクノロジーの進歩や標的治療薬・診断薬の需要増加により、大きな成長を遂げています。アプタマーは短い一本鎖DNAまたはRNA分子で、タンパク質、細胞、低分子などの特定のターゲットに選択的に結合することができます。特異性が高く、免疫原性が低く、合成が容易であることから、多くの生物医学的応用において、抗体の代替品として有望視されています。市場を前進させる重要な要因の一つは、個別化医療への関心の高まりです。アプタマーは、精密治療の開発において重要な役割を果たし、副作用を軽減したオーダーメイドの治療選択肢を提供します。バイオマーカーを特定し、腫瘍細胞に直接薬剤を送達する可能性を研究者が探っているため、がん診断および治療におけるその有用性が特に注目されています。例えば、2023年1月、マレーシアのバイオテクノロジー新興企業Biogenes Technologiesは、PESBからシリーズAで570万米ドルの資金を獲得しました。この投資は、フィリピンやインドネシアを含む東南アジア全域での独自技術プラットフォームの拡大を支援するものです。また、年間1,000万個の検査キットを生産し、アプタマーベースの診断ソリューションの開発を進めることを目標としています。

治療薬に加え、アプタマーはバイオセンサーや分子イメージングなどの診断プラットフォームにも広く利用されています。アプタマーは、迅速かつ正確で、費用対効果の高い結果を提供できるため、ポイントオブケア検査に最適です。アプタマーは研究ツールやアッセイに組み込まれ、分子生物学的手法の効率を高めています。市場はまた、製薬会社、研究機関、バイオテクノロジー新興企業間の共同研究の増加を目の当たりにしており、技術革新を促進し、アプタマー応用の展望を広げています。しかし、規制の複雑さ、臨床検証の限界、確立された抗体技術との競合といった課題にはまだ対処する必要があります。これらのハードルにもかかわらず、アプタマーの選別と改変技術における継続的な技術的進歩は、現在の限界を克服し、より広範な採用への道を開くと期待されています。R&Dへの継続的な投資とアプタマーの機能性についての理解の深まりにより、世界のアプタマー市場は今後数年で着実に拡大し、最新の診断と標的治療薬の重要な構成要素になることが予想されます。

主な市場促進要因

標的治療および個別化治療に対する需要の高まり

主な市場課題

既存技術との競合

主要市場動向

研究開発投資の拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のアプタマー市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（DNAアプタマー、XNAアプタマー、RNAアプタマー）
  • 技術別（SELEX、その他）
  • 用途別（治療薬開発、研究開発、診断、その他）
  • エンドユーザー別（製薬・バイオテクノロジー企業、学術・研究機関、CRO、その他）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024年）
• 市場マップ

第6章 北米のアプタマー市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のアプタマー市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のアプタマー市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のアプタマー市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのアプタマー市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界のアプタマー市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Aptamer Group
• Raptamer Discovery Group
• Somalogic Inc.
• Aptamer Sciences, Inc.
• Aptagen LLC.
• Maravai Lifesciences.
• Kaneka Corporation.
• Neoventures Biotechnology Inc.
• Aptus Biotech.
• Base Pair Biotechnologies.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Aptamers Market was valued at USD 2.05 billion in 2024 and is expected to reach USD 3.07 billion by 2030 with a CAGR of 7.11% during the forecast period. The global aptamers market is experiencing significant growth, driven by advancements in biotechnology and increasing demand for targeted therapeutics and diagnostics. Aptamers are short, single-stranded DNA or RNA molecules that can bind selectively to specific targets, such as proteins, cells, or small molecules. Their high specificity, low immunogenicity, and ease of synthesis make them a promising alternative to antibodies in many biomedical applications. One of the key factors propelling the market forward is the growing interest in personalized medicine. Aptamers play a crucial role in the development of precision therapies, offering tailored treatment options with reduced side effects. Their utility in cancer diagnostics and therapeutics has gained particular attention, as researchers explore their potential in identifying biomarkers and delivering drugs directly to tumor cells. For instance, in January 2023, Malaysian biotech startup Biogenes Technologies secured $5.7 million in Series A funding from PESB. The investment supports expansion of proprietary technology platforms across Southeast Asia, including the Philippines and Indonesia. It also aims to scale production to 10 million test kits annually and advance the development of aptamer-based diagnostic solutions.

In addition to therapeutics, aptamers are being widely utilized in diagnostic platforms, including biosensors and molecular imaging. Their ability to provide rapid, accurate, and cost-effective results makes them ideal for point-of-care testing, which is increasingly in demand across healthcare systems worldwide. Aptamers are being integrated into research tools and assays, enhancing the efficiency of molecular biology techniques. The market is also witnessing a rise in collaborations between pharmaceutical companies, research institutions, and biotech startups, fostering innovation and expanding the aptamer application landscape. However, challenges such as regulatory complexities, limited clinical validation, and competition from established antibody technologies still need to be addressed. Despite these hurdles, ongoing technological advancements in aptamer selection and modification techniques are expected to overcome current limitations, paving the way for broader adoption. With continuous investments in R\&D and a growing understanding of aptamer functionalities, the global aptamers market is poised to expand steadily in the coming years, becoming a vital component of modern diagnostics and targeted therapeutics.

Key Market Drivers

Rising Demand for Targeted and Personalized Therapies

The rising demand for targeted and personalized therapies is a significant driver of growth in the global aptamers market. As the healthcare industry shifts toward precision medicine, there is increasing emphasis on treatments that are tailored to individual patient profiles. Aptamers, due to their high specificity and binding affinity to molecular targets, play a central role in this shift. Their unique ability to bind selectively to a wide range of biomarkers makes them highly suitable for use in targeted drug delivery and disease-specific diagnostics. In oncology, for example, aptamers can be designed to recognize cancer-specific antigens, enabling the delivery of therapeutic agents directly to tumor cells. This approach not only enhances treatment efficacy but also reduces damage to healthy tissues, minimizing side effects and improving patient outcomes. The demand for such precision-targeted treatments continues to grow, especially as more cancers and chronic diseases are better understood at the molecular level. Aptamers also support the development of companion diagnostics, which are essential in identifying patients who are most likely to benefit from specific therapies. Their synthetic nature allows for rapid and cost-effective production, which aligns well with the fast-paced needs of personalized healthcare.

The integration of aptamers in personalized therapeutic platforms reflects a broader transformation in clinical practice. With continued research and innovation, their role is expanding from diagnostic support to active components of targeted treatments. This shift is fueling the expansion of the aptamers market, as more pharmaceutical and biotech companies invest in developing aptamer-based therapeutics that address the growing demand for individualized care.

Key Market Challenges

Competition from Established Technologies

Competition from established technologies, particularly monoclonal antibodies, presents a major challenge to the growth of the global aptamers market. Monoclonal antibodies have been widely used in diagnostics and therapeutics for decades and are regarded as the gold standard due to their proven efficacy, high specificity, and long history of clinical use. Their success across various disease areas, including oncology, autoimmune disorders, and infectious diseases, has created a strong foundation of trust among clinicians, researchers, and regulatory bodies. Aptamers, while offering advantages such as lower immunogenicity and easier synthesis, still face difficulty gaining traction in a market dominated by antibodies. Monoclonal antibodies benefit from well-established manufacturing protocols, large-scale production infrastructure, and clear regulatory pathways. These factors contribute to their continued preference in drug development and diagnostic tool design. The extensive investment and familiarity with antibody technologies make healthcare providers less likely to adopt newer, less-proven alternatives unless they offer significantly better performance or cost savings. The large volume of existing antibody-based products also means that aptamers must demonstrate superior or unique capabilities to differentiate themselves. The inertia created by widespread clinical use, established supply chains, and extensive validation of antibody-based systems poses a barrier for aptamer developers. Convincing stakeholders to transition to or invest in aptamer platforms requires not only innovation but also clear clinical and economic benefits. Overcoming this competitive landscape will depend on strategic positioning, targeted applications where aptamers outperform antibodies, and generating compelling evidence of their real-world utility. Without this, aptamers may remain limited to niche applications despite their potential.

Key Market Trends

Growing Investment in Research and Development

Growing investment in research and development (R&D) is significantly shaping the landscape of the global aptamers market. As interest in aptamer technology expands, companies and research institutions are dedicating substantial resources to innovate and refine aptamer selection, synthesis, and application methods. This surge in funding accelerates the pace of discovery and enhances the quality and functionality of aptamers, opening new possibilities in both diagnostics and therapeutics. Pharmaceutical and biotechnology firms are particularly active in this space, recognizing aptamers as promising alternatives to traditional biologics. Investments focus on overcoming existing challenges such as stability, delivery, and large-scale manufacturing. Increased R&D efforts are resulting in novel chemical modifications and conjugation techniques that improve aptamer performance and broaden their potential clinical uses.

Collaborations between academic institutions and industry players are becoming more common, facilitating knowledge exchange and the development of cutting-edge technologies. These partnerships help translate laboratory breakthroughs into commercially viable products more efficiently. Research organizations are also exploring the integration of computational methods, including artificial intelligence and machine learning, to optimize aptamer design and predict binding efficiencies, which further enhances development speed and reduces costs. Government funding and supportive policies play an important role by encouraging innovation in the field and providing grants for projects focusing on aptamer-based solutions. This support boosts confidence among private investors and companies, fostering a favorable environment for sustained R&D investment. The continuous growth in R&D spending is expected to drive significant advancements in aptamer technology, enabling more effective diagnostics, personalized therapies, and targeted drug delivery systems. This momentum will be crucial for expanding the market and establishing aptamers as key players in the future of medical science.

Key Market Players

• Aptamer Group
• Raptamer Discovery Group
• Somalogic Inc.
• Aptamer Sciences, Inc.
• Aptagen LLC.
• Maravai Lifesciences.
• Kaneka Corporation.
• Neoventures Biotechnology Inc.
• Aptus Biotech.
• Base Pair Biotechnologies.

Report Scope:

In this report, the Global Aptamers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Aptamers Market, By Type:

• DNA Aptamers
• XNA Aptamers
• RNA Aptamers

Aptamers Market, By Technology:

• SELEX
• Others

Aptamers Market, By Application:

• Therapeutics Development
• Research & Development
• Diagnostics
• Others

Aptamers Market, By End user:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Contract Research Organizations
• Others

Aptamers Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Aptamers Market.

Available Customizations:

Global Aptamers Market report with the given market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Aptamers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (DNA Aptamers, XNA Aptamers, RNA Aptamers)
  • 5.2.2. By Technology (SELEX, Others)
  • 5.2.3. By Application (Therapeutics Development, Research & Development, Diagnostics, Others)
  • 5.2.4. By End user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations, Others)
  • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Aptamers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End user
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Aptamers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Aptamers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Aptamers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Aptamers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End user
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Aptamers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Aptamers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Aptamers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Aptamers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Aptamers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Aptamers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End user
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Aptamers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Aptamers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Aptamers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Aptamers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Aptamers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Aptamers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End user
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Aptamers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Aptamers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Aptamers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Aptamers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End user
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Aptamers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Aptamers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Aptamers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Aptamers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

15.1 Aptamer Group

15.2 Raptamer Discovery Group

15.3 Somalogic Inc.

15.4 Aptamer Sciences, Inc.

15.5 Aptagen LLC.

15.6 Maravai Lifesciences.

15.7 Kaneka Corporation.

15.8 Neoventures Biotechnology Inc.

15.9 Aptus Biotech.

15.10 Base Pair Biotechnologies.

16. Strategic Recommendations

17. About Us & Disclaimer